The Top 5 Analyst Questions From ANI Pharmaceuticals's Q1 Earnings Call
Is now the time to buy ANIP? Find out in our full research report (it's free).
Revenue: $197.1 million vs analyst estimates of $179.6 million (43.4% year-on-year growth, 9.8% beat)
Adjusted EPS: $1.70 vs analyst estimates of $1.38 (23% beat)
Adjusted EBITDA: $50.75 million vs analyst estimates of $42.4 million (25.7% margin, 19.7% beat)
The company lifted its revenue guidance for the full year to $780.5 million at the midpoint from $766 million, a 1.9% increase
Management raised its full-year Adjusted EPS guidance to $6.45 at the midpoint, a 2.2% increase
EBITDA guidance for the full year is $200 million at the midpoint, above analyst estimates of $195.8 million
Operating Margin: 13.3%, down from 14.8% in the same quarter last year
Market Capitalization: $1.31 billion
While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Gary Nachman (Raymond James) pressed on whether the new pre-filled syringe for Cortrophin Gel could materially expand use and asked about the impact of added sales reps. CEO Nikhil Lalwani said early feedback was positive and that the expanded field force is gaining traction, but no further rep additions are planned for now.
Faisal Khurshid (Leerink Partners) sought clarity on commercial access barriers affecting the retina segment, particularly regarding Medicare. Lalwani explained that lack of foundation funding for co-pay support in Q1 reduced access but the company is exploring alternative pathways and expects improvement.
Vamil Divan (Guggenheim Securities) asked about the potential impact of upcoming clinical trial results for retina therapies and the significance of Prucalopride exclusivity for generics. Management confirmed that positive trial outcomes could broaden ILUVIEN's use, and that generics revenue will dip post-exclusivity before rebounding.
David Amsellem (Piper Sandler) questioned the sustainability of payer dynamics as the Cortrophin category grows and inquired about surprises in the Alimera acquisition. Lalwani asserted that payers value competition in ACTH and expressed confidence in resolving challenges related to the retina portfolio.
Ekaterina Knyazkova (J.P. Morgan) probed which indications are driving Cortrophin Gel growth and whether ANI's U.S. manufacturing footprint could be leveraged if tariffs are enacted. Lalwani detailed broad-based growth across specialties and confirmed spare capacity to meet potential tariff-driven demand.
In the coming quarters, StockStory analysts will monitor (1) the pace of Cortrophin Gel adoption enabled by the pre-filled syringe and outreach to new prescribers, (2) the recovery in retina segment sales as commercial changes and market access initiatives take effect, and (3) sustained momentum in generics following the expiration of Prucalopride exclusivity. Any developments regarding pharmaceutical tariffs and the ongoing CG Oncology royalty litigation may also influence results.
ANI Pharmaceuticals currently trades at $65.50, down from $71.67 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it's free).
The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.
While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Michael Burry is Betting Big on This 1 S&P 500 Stock That's Down 40% in 2025
Michael Burry, the legendary investor famous for predicting the 2008 housing crisis, has taken a new position in UnitedHealth Group (UNH) through his Scion Asset Management, according to 13F filings for the second quarter. UnitedHealth stock has been battered in 2025, falling nearly 60% from all-time highs through last Thursday before surging 12% on Friday, Aug. 15 following Warren Buffett's surprise disclosure of a $1.6 billion stake. The healthcare giant has faced intense scrutiny as the poster child for America's rising healthcare costs. More News from Barchart As SoFi Launches International Money Transfer Services, How Should You Play SOFI Stock? This Cannabis Stock Just Transformed Into a Bitcoin Treasury Play. Should You Buy Shares Now? Profiting from Volatility: CRWV Long Straddle Trade Setup Our exclusive Barchart Brief newsletter is your FREE midday guide to what's moving stocks, sectors, and investor sentiment - delivered right when you need the info most. Subscribe today! The nation's largest private health insurer is navigating multiple headwinds. CEO Andrew Witty stepped down in May after the company pulled its annual earnings outlook. A Justice Department investigation into Medicare billing practices has added regulatory pressure, while the company's revised 2025 outlook fell well short of Wall Street expectations. Burry's investment suggests he sees opportunity amid the turmoil. This adds on to Buffett's investment, which analysts say 'represents a big vote of confidence' and could provide a 'trading floor' for the managed care sector. With UnitedHealth trading at deeply discounted levels despite its market-leading position, contrarian investors like Burry may be betting the current challenges are temporary while the long-term healthcare demand thesis remains intact. Is UNH Stock a Good Buy Right Now? UnitedHealth Group's Q2 earnings call revealed near-term pressures, but also highlighted compelling reasons why the healthcare giant could emerge stronger for long-term investors. UnitedHealth's medical costs have been rising faster than expected. The company initially estimated costs to go up about 7.5% this year, but they're actually rising even more. For 2026, UnitedHealth is being much more conservative and assuming medical costs will rise by nearly 10%. The company is responding by: Raising prices - Charging higher premiums to customers to cover the increased medical costs. Cutting benefits - Reducing what services insurance plans will cover or making customers pay more out of pocket. Using narrower networks - Limiting which doctors and hospitals customers can use (typically to cheaper, more efficient providers). These changes take time to work through the system. Most of UnitedHealth's contracts renew on Jan. 1, so the 2026 changes will start helping their profits next year, with full benefits showing up by 2027. CEO Stephen Hemsley has initiated comprehensive operational reforms, including monthly business reviews, enhanced forecasting processes, and significant management changes across Optum. Moreover, UNH is investing heavily in AI capabilities and modernizing its technology stack, which should drive long-term efficiency gains. Despite execution challenges, OptumHealth's value-based care model continues to demonstrate superior outcomes with 20% fewer hospitalizations and 11% fewer ER visits versus. Mature patient cohorts (2021 and prior) are achieving 8%-plus margins, proving the model's viability once properly executed. UNH stock remains the dominant player in multiple healthcare segments with unmatched scale advantages. Its integrated model combining insurance, pharmacy benefits, and care delivery creates defensive moats that competitors struggle to replicate. What Is the Target Price for UNH Stock? Analysts tracking UNH stock forecast adjusted net income to expand from an estimated $16.24 per share in 2025 to $32.22 per share in 2029. Today, UNH stock trades at a forward price-earnings multiple of 19x, which is in line with the 10-year average. If it trades at a similar multiple, the healthcare stock should trade around $608 in early 2029, indicating an upside potential of over 100% from current levels. Out of the 25 analysts covering UNH stock, 15 recommend 'Strong Buy,' two recommend 'Moderate Buy,' six recommend 'Hold,' and two recommend 'Strong Sell.' The average UNH stock price target is $306.62, roughly in line with the current trading price. On the date of publication, Aditya Raghunath did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Boston Globe
3 hours ago
- Boston Globe
Karishma Manzur launches progressive campaign for US Senate in N.H., taking on Chris Pappas for Democratic nomination
Manzur said she supports Medicare for all, livable wages, affordable housing, and childcare subsidies. She framed her candidacy as an effort to 'break the grip of big money' on politics, by electing someone who 'can't be bought.' Advertisement 'It's New Hampshire versus the billionaires,' she said. Get N.H. Morning Report A weekday newsletter delivering the N.H. news you need to know right to your inbox. Enter Email Sign Up Manzur's launch video didn't criticize Pappas by name, but it alluded to his handling of concerns about Israel's war with Hamas in Gaza. When the voiceover said New Hampshire 'deserves a leader who listens to the people, In recent months, Pappas has expressed support for ceasefire negotiations, while continuing to endorse efforts to aid in Advertisement The topic is one where Manzur has struck a more pointed tone. She has written op-eds Manzur previously served on the board for Pappas, who currently represents New Hampshire's 1st Congressional District, was the first person to declare his Senate candidacy, in April, after Democratic Senator Jeanne Shaheen announced in March she wouldn't seek re-election next year. The leading contenders for the Republican nomination, meanwhile, are former US senator Steven Porter can be reached at
Yahoo
3 hours ago
- Yahoo
How Should We Budget for Retirement at 65 With $1.5M and $4,200 Monthly in Social Security?
Age 65 is a major transition for many individuals as they shift to thinking about retirement and begin to contemplate benefits like Social Security and Medicare. Retirement planning means you'll have to consider taxes, healthcare, your retirement budget and more. With $1.5 million in an IRA and two Social Security payments to rely on, a married couple should have some flexibility for retirement, but their individual circumstances and how they strategize can make a big difference in their quality of life. Here's how to think about it. If you need help planning and saving for retirement, consider working with a . Benefits and Savings If you're approaching retirement, the first area to examine is your expected savings, income and planned retirement date. Basically, how much money will you have and when? Your income, both from your portfolio and your benefits, will depend heavily on when you choose to retire. For example, let's say you're currently 65, have started collecting Social Security and your IRA is invested in a mixed-asset portfolio with an 8% annual rate of return. If you retire at 67 (full retirement age) and don't plan to continue contributing to your account, here's what your finances could look like at retirement: Age: 67 IRA: $1.75 million Benefits: $4,200/month ($50,400/year) On the other hand, say that you wait until age 70 to retire and claim your Social Security. Again, take an 8% average return on a mixed-asset portfolio and discount additional contributions. By retirement you might have: Age: 70 IRA: $2.2 million Benefits: $5,208/month ($62,496/year) By delaying Social Security until age 70, you and your spouse's benefits increase to more than $5,200 per month, increasing your annual budget by nearly $13,000. For the purposes of this article, we'll assume that you retire at 67. The point here is that delaying retirement can help you increase your retirement budget in many cases. And if you need help determining a suitable time to retire, connect with a financial advisor and talk it over. Spending and Income SmartAsset and Yahoo Finance LLC may earn commission or revenue through links in the content below. Once you know how much income you can expect to generate each year, the next step is to make a budget for it. 'When determining a retirement budget, the goal isn't just to ensure your money lasts, but to ensure it lasts in a way that maintains your quality of life,' said Aaron Cirksena, CEO and Founder of MDRN Capital. 'With $1.5 million in an IRA and a steady stream of Social Security benefits, it's about balancing the financial priorities with personal priorities. You calculate based on expected needs and foreseeable expenses, but also on the less tangible aspects — like aspirations, goals, dreams and the peace of mind.' Your income will depend on a variety of factors, including how you invest and manage your money, including your withdrawals. A commonly applied rule of thumb is withdrawing 4% of your portfolio in your first year of retirement and then increasing subsequent withdrawals by the annual rate of inflation. This increases the likelihood that your savings last through retirement. In this simplistic example, your income in the first year might be: IRA withdrawals: $70,000 Social Security: $50,400 Combined income: $120,400 For individuals with a lower risk tolerance who might not want to actively manage their money, an annuity might be an option. Alternatively, you can adjust your withdrawal rate up or down depending on your needs and portfolio performance over time. Keep in mind that a retirement planner can help you calculate how much you can afford to withdraw from savings each year. How to Budget Your Retirement From there, as Cirksena says, it's about balancing your spending and lifestyle. For example, how much do you spend each month on housing? How much will you spend on food? How much are your other recurring monthly bills? How much money will you need to allocate for long-term care and gap insurance? And account for the local cost of living, keeping in mind that expenses and rents in high-cost urban areas tend to inflate much faster than the national average. Then, consider your lifestyle and the discretionary spending that comes with it. What kind of hobbies and habits do you enjoy? For example, do you want to travel in retirement? Do you enjoy eating out or attending live shows? Do you like to buy new clothes? Combined, this will tell you the spending side of your retirement budget. But if you need guidance as begin to build your spending plan for retirement, consider connecting with a financial advisor. Taxes and RMDs Finally, you will need to plan for taxes and, relatedly, required minimum distributions (RMDs). You'll need to pay income taxes on withdrawals from a traditional IRA. Your tax rate will depend on your adjusted gross income (AGI), as it does preretirement. Your AGI will include your IRA withdrawals, some of your Social Security income, as well as income from other taxable sources. With $120,400 in total income between you and your spouse, you would likely pay income taxes on 85% of your Social Security benefits. RMDs will also dictate how much of money you'll need to withdraw from your IRA. For example, say that you still have your entire $1.75 million in your IRA at age 73 (the age at which RMDs begin). You would need to withdraw at least $66,037 to avoid tax penalties for not taking the proper RMD. While this would be less than you would withdraw if you followed the 4% rule, knowing how much you're required to withdraw is nonetheless important. One popular retirement tax strategy for people with IRAs is to use a Roth conversion to settle up your taxes with the federal government now rather than in retirement – this will also help you eliminate RMDs. However, you'll owe taxes upfront on Roth conversions and won't be able to use the converted money for five years after making the switch. Consider speaking with a financial advisor to plan for retirement taxes and RMDs. Bottom Line Your retirement budget is based on two main factors: your assets and your spending. To create a sustainable budget, you'll need to make sure those numbers meet in the middle. Start by assessing your assets and determining how much income then can generate. Then, examine your spending needs. If those numbers don't match, you need to make some changes. Tips for Managing Your Retirement Budget Managing your money in retirement is critical. Ideally, this phase of your life will be almost as long as your working years, so keeping your money invested and growing is generally very important. But you need to balance that with the need to keep your money safe, since you can't easily go back to work and earn more of it. Here's how to start thinking about that balance. A financial advisor can help you build a comprehensive retirement plan. Finding a financial advisor doesn't have to be hard. SmartAsset's free tool matches you with up to three vetted financial advisors who serve your area, and you can have a free introductory call with your advisor matches to decide which one you feel is right for you. If you're ready to find an advisor who can help you achieve your financial goals, get started now. Photo credit: © © Shumitskaya, © The post We're 65 With $1.5 Million in an IRA and $4,200 Per Month in Social Security. What's Our Retirement Budget? appeared first on SmartReads by SmartAsset. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
